BR112018008585A2 - peptide macrocycles against acinotobacter baumannii - Google Patents
peptide macrocycles against acinotobacter baumanniiInfo
- Publication number
- BR112018008585A2 BR112018008585A2 BR112018008585A BR112018008585A BR112018008585A2 BR 112018008585 A2 BR112018008585 A2 BR 112018008585A2 BR 112018008585 A BR112018008585 A BR 112018008585A BR 112018008585 A BR112018008585 A BR 112018008585A BR 112018008585 A2 BR112018008585 A2 BR 112018008585A2
- Authority
- BR
- Brazil
- Prior art keywords
- acinotobacter
- baumannii
- peptide macrocycles
- macrocycles against
- formula
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
a presente invenção proporciona compostos da fórmula (i) em que x1 a x8 e r1 a r8 são tais como descritos neste contexto, bem como os seus sais farmaceuticamente aceitáveis. além disso, a presente invenção relaciona-se com a manufatura dos compostos da fórmula (i), composições farmacêuticas que compreendem os mesmos e seu uso como medicamentos para o tratamento de enfermidades e infecções causadas pelo acinotobacter baumannii.The present invention provides compounds of formula (I) wherein x1 to x8 and r1 to r8 are as described herein, as well as their pharmaceutically acceptable salts. furthermore, the present invention relates to the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments for the treatment of diseases and infections caused by acinotobacter baumannii.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15191743 | 2015-10-27 | ||
| PCT/EP2016/075499 WO2017072062A1 (en) | 2015-10-27 | 2016-10-24 | Peptide macrocycles against acinetobacter baumannii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018008585A2 true BR112018008585A2 (en) | 2018-10-30 |
Family
ID=54539821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018008585A BR112018008585A2 (en) | 2015-10-27 | 2016-10-24 | peptide macrocycles against acinotobacter baumannii |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR106511A1 (en) |
| BR (1) | BR112018008585A2 (en) |
| MA (1) | MA43103B1 (en) |
-
2016
- 2016-10-24 MA MA43103A patent/MA43103B1/en unknown
- 2016-10-24 BR BR112018008585A patent/BR112018008585A2/en active Search and Examination
- 2016-10-27 AR ARP160103280A patent/AR106511A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA43103B1 (en) | 2020-08-31 |
| AR106511A1 (en) | 2018-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017013708A2 (en) | Peptide macrocycles against acinetobacter baumannii. | |
| BR112018009281A2 (en) | compositions for treating spinal muscular atrophy | |
| BR112018077015A2 (en) | boronic acid derivatives and their therapeutic uses | |
| BR112017020837A2 (en) | polycyclic carbamoylpyridone compounds and their pharmaceutical use | |
| BR112018008880A2 (en) | As a TLR7 agonist of the 7- (thiazol-5-yl) pyrrolopyrimidine compound | |
| BR112018076169A2 (en) | azabenzimidazole derivatives as pi3k beta inhibitors | |
| CR20160518A (en) | COMPOUNDS TO TREAT SPINAL MUSCLE ATROPHY | |
| CR20150628A (en) | DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
| BR112017002811A2 (en) | pyrrolopyrimidine compounds used as tlr7 agonist | |
| BR112018070123A2 (en) | oxiesterós and methods of use thereof | |
| BR112015032710A2 (en) | bromodomain inhibitors | |
| BR112015026023A2 (en) | 2-aminopyrido [4,3-d] pyrimidin-5-one derivatives and their use as wee-1 inhibitors | |
| BR112014018990A8 (en) | BENZOTHIAZOLE-6-ILACETIC ACID DERIVATIVES AND THEIR USE FOR TREATMENT OF AN INFECTION | |
| BR112017004741A2 (en) | compounds and compositions as raf kinase inhibitors | |
| BR112017026132A2 (en) | substituted pyridines and methods of use | |
| BR112018068532A2 (en) | lsd1 inhibitor combinations for the treatment of hematologic malignancies | |
| BR112018011969A2 (en) | heteroaromatic compounds as btk inhibitors | |
| BR112017023038A2 (en) | imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators | |
| BR112017009012A2 (en) | six-membered benzo ring derivatives as a dpp-4 inhibitor and their use | |
| BR112017019653A2 (en) | fused bicyclic heteroaryl derivatives having activity as phd inhibitors | |
| BR112017001334A2 (en) | imidazopyridazine compounds, their use and pharmaceutical composition comprising them | |
| BR112015022758A2 (en) | pyrrolidine derivatives, pharmaceutical compositions containing them and their use in therapy | |
| BR112018007068A2 (en) | quinoxaline and pyridopyrazine derivatives as pi3kbeta inhibitors | |
| BR112017015116A2 (en) | (r) -2-methylpiperazine derivatives as cxcr3 receptor modulators | |
| BR112019007863A2 (en) | innovative naphthyridinone derivatives and their use in the treatment of arrhythmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notice of approval relating to section 229 industrial property law | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure |